+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopreservation Market Report 2023-2033

  • PDF Icon

    Report

  • 276 Pages
  • February 2023
  • Region: Global
  • Visiongain
  • ID: 5806168
The Biopreservation Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Upsurge in R&D and Product Development to Bolster Market Growth

The companies operating in the biopreservation market, research associations, and non- governmental organizations, among other stakeholders, are focused on increasing their efforts in research and development of innovative techniques in the field of biopreservation industry. For instance, in November 2021, Spain was formally recognised as a new Observer in the European research infrastructure partnership BBMRI- ERIC (Biobanks and Biomolecular Resources Research Infrastructure Consortium), with an emphasis on biobanking and biomolecular research.

On the other hand, the high cost of medical instruments, including their initial purchase price and ongoing maintenance expenses, is a major factor that is expected to hinder the growth of the market. The high cost of medical instruments can make it difficult for healthcare providers and institutions to purchase and maintain these tools. The cost of purchasing advanced and specialized instruments can be quite high, and the cost of maintaining and repairing these instruments can also add up over time. This financial burden can limit the adoption and usage of these instruments, which can in turn slow down the growth of the market.

Additionally, there is a risk of tissue injury during the preservation, which can also lead to negative outcomes and potentially harm the market growth. These factors combined are likely to challenge market growth over the forecast period.

Lack of Efficient Temperate Control Could Impede Industry Development

One of the main challenges for the development of new storage technologies is the need to maintain and regulate the room temperature storage. For instance, vaccines save almost 3 million lives each year in the United States, but due to improper refrigeration and storage, vaccines worth about US$20 million are lost or abandoned each year. The frequent tissue or cell injury that results from freezing and thawing is impeding market revenue. Nevertheless, future market projections will be driven by continuous research into the durability of products like genes, vaccines, and other bio preserved products.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Biopreservation Market evolving?
  • What is driving and restraining the Biopreservation Market?
  • How will each Biopreservation submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each Biopreservation submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading Biopreservation Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Biopreservation product development projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of Biopreservation product development projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Biopreservation Market?
  • Where is the Biopreservation Market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C- suite?

You need to discover how this will impact the Biopreservation Market today, and over the next 10 years:

  • Our 277- page report provides 115 tables and 174 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in- depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Biopreservation Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biopreservation product prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Product

  • Equipment
  • Freezers
  • Refrigerators
  • Consumables
  • Liquid Nitrogen
  • Media
  • Pre- formulated
  • Home- brew
  • Laboratory Information Management Systems (LIMS)

By Application

  • Regenerative Medicine
  • Cell Therapy
  • Gene Therapy
  • Others
  • Biobanking
  • Human Eggs
  • Human Sperm
  • Veterinary IVF
  • Drug Discovery

By Cell Provider

  • CD34+
  • CD19+
  • MSC
  • iPSC
  • hESC
  • Tumour cells
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Biopreservation Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • Arctiko
  • Azenta
  • BioLife Solutions Inc.
  • Biomatrica
  • Cryoport Systems, LLC
  • Eppendorf SE
  • Helmer Scientific Inc.
  • Merck KGaA
  • PHC Holdings Corporation
  • Qiagen
  • Taylor- Wharton Cryogenics LLC
  • Thermo Fisher Scientific Inc.
  • VWR International
Overall world revenue for Biopreservation Market, 2023 to 2033 in terms of value the market will surpass US$5,861.0 million in 2023, this work calculates. We predict strong revenue growth through to 2033. this work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biopreservation Market, 2023 to 2033 report help you?

In summary, this 270+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Biopreservation Market, 2023 to 2033 Market, with forecasts for Type of Product, Type of Application, Type of Cell provider, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the Biopreservation Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles of the major companies involved in the Biopreservation Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Biopreservation Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biopreservation Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Investments in Furthering Research and Development
3.2.1.2 Increasing Applications of Biopreservation Techniques
3.2.1.3 Rising Demand for Regenerative Medicines
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulations Pertaining to Biopreservation Industry
3.2.2.2 Lack of Media Solutions Storing Bio-specimens at Room Temperature
3.2.3 Market Opportunities
3.2.3.1 Surge in Fertility Preservation Programmes
3.2.3.2 Emergence of Biobanking Sector
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Biopreservation Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Biopreservation Market Size Estimation and Forecast by Product
4.4 Equipment
4.4.1 Biopreservation Market Forecast by Equipment,2023-2033 (US$ Mn)
4.4.1.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.1.2 Market Share by Region, 2023 & 2033 (%)
4.4.2 Freezers
4.4.2.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Refrigerators
4.4.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Consumables
4.4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.5 Liquid Nitrogen
4.4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.5.2 Market Share by Region, 2023 & 2033 (%)
4.5 Media
4.5.1 Biopreservation Market Forecast by Media, 2023-2033 (US$ Mn)
4.5.1.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.1.2 Market Share by Region, 2023 & 2033 (%)
4.5.2 Pre-formulated
4.5.2.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Home-brew
4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.6 Laboratory Information Management Systems (LIMS)
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
5 Biopreservation Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Biopreservation Market Size Estimation and Forecast by Application
5.4 Regenerative Medicine
5.4.1 Biopreservation Market Forecast by Regenerative Medicine, 2023-2033 (US$ Mn)
5.4.1.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.1.2 Market Share by Region, 2023 & 2033 (%)
5.4.2 Cell Therapy
5.4.2.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2.2 Market Share by Region, 2023 & 2033 (%)
5.4.3 Gene Therapy
5.4.3.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.3.2 Market Share by Region, 2023 & 2033 (%)
5.4.4 Others
5.4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Biobanking
5.5.1 Biopreservation Market Forecast by Biobanking, 2023-2033 (US$ Mn)
5.5.1.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.1.2 Market Share by Region, 2023 & 2033 (%)
5.5.2 Human Eggs
5.5.2.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2.2 Market Share by Region, 2023 & 2033 (%)
5.5.3 Human Sperm
5.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.3.2 Market Share by Region, 2023 & 2033 (%)
5.5.4 Veterinary IVF
5.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.4.2 Market Share by Region, 2023 & 2033 (%)
5.6 Drug Discovery
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 Biopreservation Market Analysis by Cell Provider
6.1 Key Findings
6.2 Cell Provider Segment: Market Attractiveness Index
6.3 Biopreservation Market Size Estimation and Forecast by Cell Provider
6.4 CD34+
6.4.1 Market Size by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 CD19+
6.5.1 Market Size by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 MSC (Mesenchymal stem cells)
6.6.1 Market Size by Region, 2023-2033 (US$ Mn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 iPSC (Induced Pluripotent Stem Cells)
6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 hESC (Human embryonic stem cells)
6.8.1 Market Size by Region, 2023-2033 (US$ Mn)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Tumor Cells
6.9.1 Market Size by Region, 2023-2033 (US$ Mn)
6.9.2 Market Share by Region, 2023 & 2033 (%)
6.10 Others
6.10.1 Market Size by Region, 2023-2033 (US$ Mn)
6.10.2 Market Share by Region, 2023 & 2033 (%)
7 Biopreservation Market Analysis by Region
7.1 Key Findings
7.2 Regional Segment: Market Attractiveness Index
7.3 Biopreservation Market Size Estimation and Forecast
8 North America Biopreservation Market Analysis
8.1 Key Findings
8.2 North America Biopreservation Market Attractiveness Index
8.3 North America Biopreservation Market by Country, 2023, 2028 & 2033 (US$ Mn)
8.4 North America Biopreservation Market Size Estimation and Forecast by Country
8.5 North America Biopreservation Market Size Estimation and Forecast by Product
8.6 North America Biopreservation Market Size Estimation and Forecast by Application
8.7 North America Biopreservation Market Size Estimation and Forecast by Cell Provider
8.8 U.S. Biopreservation Market Analysis
8.9 Canada Biopreservation Market Analysis
9 Europe Biopreservation Market Analysis
9.1 Key Findings
9.2 Europe Biopreservation Market Attractiveness Index
9.3 Europe Biopreservation Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 Europe Biopreservation Market Size Estimation and Forecast by Country
9.5 Europe Biopreservation Market Size Estimation and Forecast by Product
9.6 Europe Biopreservation Market Size Estimation and Forecast by Application
9.7 Europe Biopreservation Market Size Estimation and Forecast by Cell Provider
9.8 Germany Biopreservation Market Analysis
9.9 France Biopreservation Market Analysis
9.10 UK Biopreservation Market Analysis
9.11 Italy Biopreservation Market Analysis
9.12 Spain Biopreservation Market Analysis
9.13 Russia Biopreservation Market Analysis
9.14 Rest of Europe Biopreservation Market Analysis
10 Asia Pacific Biopreservation Market Analysis
10.1 Key Findings
10.2 Asia Pacific Biopreservation Market Attractiveness Index
10.3 Asia Pacific Biopreservation Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Asia Pacific Biopreservation Market Size Estimation and Forecast by Country
10.5 Asia Pacific Biopreservation Market Size Estimation and Forecast by Product
10.6 Asia Pacific Biopreservation Market Size Estimation and Forecast by Application
10.7 Asia Pacific Biopreservation Market Size Estimation and Forecast by Cell Provider
10.8 Japan Biopreservation Market Analysis
10.9 China Biopreservation Market Analysis
10.10 India Biopreservation Market Analysis
10.11 Australia Biopreservation Market Analysis
10.12 South Korea Biopreservation Market Analysis
10.13 Rest of Asia Pacific Biopreservation Market Analysis
11 Latin America Biopreservation Market Analysis
11.1 Key Findings
11.2 Latin America Biopreservation Market Attractiveness Index
11.3 Latin America Biopreservation Market by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Latin America Biopreservation Market Size Estimation and Forecast by Country
11.5 Latin America Biopreservation Market Size Estimation and Forecast by Product
11.6 Latin America Biopreservation Market Size Estimation and Forecast by Application
11.7 Latin America Biopreservation Market Size Estimation and Forecast by Cell Provider
11.8 Brazil Biopreservation Market Analysis
11.9 Mexico Biopreservation Market Analysis
11.10 Rest of Latin America Biopreservation Market Analysis
12 MEA Biopreservation Market Analysis
12.1 Key Findings
12.2 MEA Biopreservation Market Attractiveness Index
12.3 MEA Biopreservation Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 MEA Biopreservation Market Size Estimation and Forecast by Country
12.5 MEA Biopreservation Market Size Estimation and Forecast by Product
12.6 MEA Biopreservation Market Size Estimation and Forecast by Application
12.7 MEA Biopreservation Market Size Estimation and Forecast by Cell Provider
12.8 GCC Biopreservation Market Analysis
12.9 South Africa Biopreservation Market Analysis
12.10 Rest of MEA Biopreservation Market Analysis
13 Company Profiles
13.1 Company Share Analysis, 2022
13.1.1 Thermo Fisher Scientific Inc.
13.1.2 PHC Holdings Corporation
13.1.3 VWR International (Avantor, Inc.)
13.2 Arctiko
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Product Benchmarking
13.2.4 Strategic Outlook
13.3 Azenta, Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 R&D, 2017-2021
13.3.3.3 Regional Market Shares, 2021
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 BioLife Solutions Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 R&D, 2017-2021
13.4.3.3 Regional Market Shares, 2021
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Biomatrica, Inc. (Exact Sciences)
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 Cryoport Systems, LLC
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.3.2 R&D, 2017-2021
13.6.3.3 Regional Market Shares, 2021
13.6.4 Product Benchmarking
13.6.5 Strategic Outlook
13.7 Eppendorf SE
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 R&D, 2017-2021
13.7.3.3 Regional Market Shares, 2021
13.7.4 Product Benchmarking
13.7.5 Strategic Outlook
13.8 Helmer Scientific Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.8.4 Strategic Outlook
13.9 Merck KGaA
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 R&D, 2017-2021
13.9.3.3 Regional Market Shares, 2021
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 PHC Holdings Corporation
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2021
13.10.3.2 R&D, 2017-2021
13.10.3.3 Regional Market Shares, 2021
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 QIAGEN
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2022
13.11.3.2 R&D, 2017-2022
13.11.3.3 Regional Market Shares, 2022
13.11.4 Product Benchmarking
13.11.5 Strategic Outlook
13.12 Taylor-Wharton
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.13 Thermo Fisher Scientific Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 R&D, 2017-2021
13.13.3.3 Regional Market Shares, 2021
13.13.4 Product Benchmarking
13.13.5 Strategic Outlook
13.14 VWR International, LLC (Avantor)
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 R&D, 2017-2021
13.14.3.3 Regional Market Shares, 2021
13.14.4 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from
14.2 Recommendations for Market Players

Companies Mentioned

  • Arctiko
  • Azenta
  • BioLife Solutions Inc.
  • Biomatrica
  • Cryoport Systems, LLC
  • Eppendorf SE
  • Helmer Scientific Inc.
  • Merck KGaA
  • PHC Holdings Corporation
  • Qiagen
  • Taylor-Wharton Cryogenics LLC
  • Thermo Fisher Scientific Inc.
  • VWR International
  • Astellas Pharma Inc.
  • B Medical Systems
  • Cell&Co BioServices
  • CSafe
  • Inception Fertility
  • Koki Holdings Co., Ltd.
  • Pantherna Therapeutics GmbH
  • Rhinostics
  • RURO Inc.
  • SciSafe
  • Sexton Biotechnologies
  • Stirling Ultracold
  • Syneos Health
  • Trans-Hit Biomarkers Inc.
  • Biobanca Multispecialista (BMS)
  • Biobanks and Biomolecular Resources Research Infrastructure Consortium
  • Biobanks South Africa (BBSA)
  • British Heart Foundation
  • Cancer Research UK
  • Chinese Maternal and Child Health Association
  • Fertility Preservation Professional Committee
  • German Biobank Alliance (GBA)
  • German Biobank Node (GBN)
  • Groupe de Recherche et d'Etude sur la Conservation Ovarienne et Testiculaire (GRECOT)
  • Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy (IRISBB)
  • National Cancer Institute (NCI)
  • National Institute for Health and Care Research
  • National Institutes of Health (NIH)
  • National Irish COVID-19 Biobank (NICB)
  • Qatar Biobank
  • South African Department of Science and Innovation (DSI)
  • Stem Cell Network
  • The Fundación Instituto Valenciano de Oncologa (IVO Biobank)
  • The Israeli Fertility Society (ILA)
  • The National Institute for Health Research (NIHR)
  • U.S. Food and Drug Administration (U.S.FDA)
  • U.S. Department of Health and Human Services (HHS)
  • UK Biobank
  • World Health Organization (WHO)